Peptide-based vectors have obtained notice for their specificity in binding to receptors overexpressed in breast cancer cells, perhaps conquering problems linked to small internalization. Clinical trials and preclinical studies are highlighted, showing the efficacy of peptide vaccines in inducing an immune reaction, with the possible to further improve survival rates https://yehudab329yvg8.law-wiki.com/user